Related Articles
miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer
MicroRNA‑125a‑3p downregulation correlates with tumorigenesis and poor prognosis in patients with non‑small cell lung cancer
Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression
MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer
MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells